ACL — Australian Clinical Labs Share News
0.000.00%
- AU$529.23m
- AU$841.21m
- AU$735.75m
Factbox: Australia Inc roiled by string of cyber attacks since late 2022
Brief: Australian Clinical Labs Says Takeover Offer For Healius Limited
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Press Digest: Wall Street Journal - Dec 15
Brief: Healius Acknowledges Australian Competition & Consumer Commission Decision on ACL Takeover
Brief: Australia's ACCC Opposes Australian Clinical Labs' Proposed Acquisition Of Healius Ltd
Brief: Australian Clinical Labs Says It Intends To Withdraw Takeover Offer For Healius
Healius slumps as Australian Clinical Labs withdraws $1 bln takeover offer
Australian Clinical Labs to withdraw its $1 bln offer to buy Healius (updated)
Australian Clinical Labs to withdraw takeover offer for Healius
Australia's competition regulator opposes Australian Clinical Labs' offer to buy Healius
Citi trims PT on Australia's Healius as earnings forecast misses estimates
Australia's Healius sinks as trading resumes after halt
Brief: Australian Clinical Labs Notes Healius' Entitlement Offer Announced On 20 Nov
Brief: Australian Clinical Labs Updates on AIC Proceedings
Brief: Australian Clinical Labs Announces Extension Of Takeover Offer Period For Healius Ltd
Brief: Australian Clinical Labs Says Negligible COVID Revenue Expected In FY24 Result
Deals of the day-Mergers and acquisitions